Global Human Vaccines Administered Orally Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
158
Industry
Healthcare Services
Regions
Global
Updated
April 2026

Report Overview


Report Overview
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.Vaccines Administered Orally have gained attention for their potential to revolutionize immunization. Unlike traditional injection-based vaccines, these oral vaccines are ingested, often through drops or capsules. They offer several advantages, including ease of administration, needle-free delivery, and improved patient compliance, especially in children. Oral vaccines stimulate both local and systemic immune responses, enhancing protection against diseases. Notable examples include the oral polio vaccine and experimental oral cholera vaccines. Despite challenges in formulation and stability, the market for Oral Vaccines is expanding as researchers explore their potential for various infectious diseases. As global health initiatives seek broader vaccine coverage, the convenience and efficacy of orally administered vaccines hold promise for widespread immunization efforts.

The global Vaccines Administered Orally market size was estimated at USD 2041.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Vaccines Administered Orally market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Vaccines Administered Orally market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Vaccines Administered Orally market.
Global Vaccines Administered Orally Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market Segmentation (by Type)
Human
Animal

Market Segmentation (by Application)
Public
Private

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Vaccines Administered Orally Market
Overview of the regional outlook of the Vaccines Administered Orally Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccines Administered Orally Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Vaccines Administered Orally, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Human Vaccines Administered Orally
    • 1.2 Key Market Segments
      • 1.2.1 Human Vaccines Administered Orally Segment by Type
      • 1.2.2 Human Vaccines Administered Orally Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Human Vaccines Administered Orally Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Human Vaccines Administered Orally Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Human Vaccines Administered Orally Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Human Vaccines Administered Orally Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Human Vaccines Administered Orally Product Life Cycle
    • 3.3 Global Human Vaccines Administered Orally Sales by Manufacturers (2020-2025)
    • 3.4 Global Human Vaccines Administered Orally Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Human Vaccines Administered Orally Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Human Vaccines Administered Orally Market Competitive Situation and Trends
      • 3.8.1 Human Vaccines Administered Orally Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Human Vaccines Administered Orally Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Human Vaccines Administered Orally Industry Chain Analysis
    • 4.1 Human Vaccines Administered Orally Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Human Vaccines Administered Orally Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Human Vaccines Administered Orally Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy – April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Human Vaccines Administered Orally Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Human Vaccines Administered Orally Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Human Vaccines Administered Orally Sales Market Share by Type (2020-2025)
    • 6.3 Global Human Vaccines Administered Orally Market Size by Type (2020-2025)
    • 6.4 Global Human Vaccines Administered Orally Price by Type (2020-2025)
  • 7 Human Vaccines Administered Orally Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Human Vaccines Administered Orally Market Sales by Application (2020-2025)
    • 7.3 Global Human Vaccines Administered Orally Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Human Vaccines Administered Orally Sales Growth Rate by Application (2020-2025)
  • 8 Human Vaccines Administered Orally Market Sales by Region
    • 8.1 Global Human Vaccines Administered Orally Sales by Region
      • 8.1.1 Global Human Vaccines Administered Orally Sales by Region
      • 8.1.2 Global Human Vaccines Administered Orally Sales Market Share by Region
    • 8.2 Global Human Vaccines Administered Orally Market Size by Region
      • 8.2.1 Global Human Vaccines Administered Orally Market Size by Region
      • 8.2.2 Global Human Vaccines Administered Orally Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Human Vaccines Administered Orally Sales by Country
      • 8.3.2 North America Human Vaccines Administered Orally Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Human Vaccines Administered Orally Sales by Country
      • 8.4.2 Europe Human Vaccines Administered Orally Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Human Vaccines Administered Orally Sales by Region
      • 8.5.2 Asia Pacific Human Vaccines Administered Orally Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Human Vaccines Administered Orally Sales by Country
      • 8.6.2 South America Human Vaccines Administered Orally Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Human Vaccines Administered Orally Sales by Region
      • 8.7.2 Middle East and Africa Human Vaccines Administered Orally Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Human Vaccines Administered Orally Market Production by Region
    • 9.1 Global Production of Human Vaccines Administered Orally by Region(2020-2025)
    • 9.2 Global Human Vaccines Administered Orally Revenue Market Share by Region (2020-2025)
    • 9.3 Global Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Human Vaccines Administered Orally Production
      • 9.4.1 North America Human Vaccines Administered Orally Production Growth Rate (2020-2025)
      • 9.4.2 North America Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Human Vaccines Administered Orally Production
      • 9.5.1 Europe Human Vaccines Administered Orally Production Growth Rate (2020-2025)
      • 9.5.2 Europe Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Human Vaccines Administered Orally Production (2020-2025)
      • 9.6.1 Japan Human Vaccines Administered Orally Production Growth Rate (2020-2025)
      • 9.6.2 Japan Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Human Vaccines Administered Orally Production (2020-2025)
      • 9.7.1 China Human Vaccines Administered Orally Production Growth Rate (2020-2025)
      • 9.7.2 China Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Merck
      • 10.1.1 Merck Basic Information
      • 10.1.2 Merck Human Vaccines Administered Orally Product Overview
      • 10.1.3 Merck Human Vaccines Administered Orally Product Market Performance
      • 10.1.4 Merck Business Overview
      • 10.1.5 Merck SWOT Analysis
      • 10.1.6 Merck Recent Developments
    • 10.2 GSK
      • 10.2.1 GSK Basic Information
      • 10.2.2 GSK Human Vaccines Administered Orally Product Overview
      • 10.2.3 GSK Human Vaccines Administered Orally Product Market Performance
      • 10.2.4 GSK Business Overview
      • 10.2.5 GSK SWOT Analysis
      • 10.2.6 GSK Recent Developments
    • 10.3 Sanofi
      • 10.3.1 Sanofi Basic Information
      • 10.3.2 Sanofi Human Vaccines Administered Orally Product Overview
      • 10.3.3 Sanofi Human Vaccines Administered Orally Product Market Performance
      • 10.3.4 Sanofi Business Overview
      • 10.3.5 Sanofi SWOT Analysis
      • 10.3.6 Sanofi Recent Developments
    • 10.4 Lanzhou Institute
      • 10.4.1 Lanzhou Institute Basic Information
      • 10.4.2 Lanzhou Institute Human Vaccines Administered Orally Product Overview
      • 10.4.3 Lanzhou Institute Human Vaccines Administered Orally Product Market Performance
      • 10.4.4 Lanzhou Institute Business Overview
      • 10.4.5 Lanzhou Institute Recent Developments
    • 10.5 Serum Institute
      • 10.5.1 Serum Institute Basic Information
      • 10.5.2 Serum Institute Human Vaccines Administered Orally Product Overview
      • 10.5.3 Serum Institute Human Vaccines Administered Orally Product Market Performance
      • 10.5.4 Serum Institute Business Overview
      • 10.5.5 Serum Institute Recent Developments
    • 10.6 Valneva
      • 10.6.1 Valneva Basic Information
      • 10.6.2 Valneva Human Vaccines Administered Orally Product Overview
      • 10.6.3 Valneva Human Vaccines Administered Orally Product Market Performance
      • 10.6.4 Valneva Business Overview
      • 10.6.5 Valneva Recent Developments
    • 10.7 Shanghai United Cell
      • 10.7.1 Shanghai United Cell Basic Information
      • 10.7.2 Shanghai United Cell Human Vaccines Administered Orally Product Overview
      • 10.7.3 Shanghai United Cell Human Vaccines Administered Orally Product Market Performance
      • 10.7.4 Shanghai United Cell Business Overview
      • 10.7.5 Shanghai United Cell Recent Developments
    • 10.8 Bibcol
      • 10.8.1 Bibcol Basic Information
      • 10.8.2 Bibcol Human Vaccines Administered Orally Product Overview
      • 10.8.3 Bibcol Human Vaccines Administered Orally Product Market Performance
      • 10.8.4 Bibcol Business Overview
      • 10.8.5 Bibcol Recent Developments
    • 10.9 PaxVax
      • 10.9.1 PaxVax Basic Information
      • 10.9.2 PaxVax Human Vaccines Administered Orally Product Overview
      • 10.9.3 PaxVax Human Vaccines Administered Orally Product Market Performance
      • 10.9.4 PaxVax Business Overview
      • 10.9.5 PaxVax Recent Developments
    • 10.10 Vabiotech
      • 10.10.1 Vabiotech Basic Information
      • 10.10.2 Vabiotech Human Vaccines Administered Orally Product Overview
      • 10.10.3 Vabiotech Human Vaccines Administered Orally Product Market Performance
      • 10.10.4 Vabiotech Business Overview
      • 10.10.5 Vabiotech Recent Developments
    • 10.11 Tiantan Biological
      • 10.11.1 Tiantan Biological Basic Information
      • 10.11.2 Tiantan Biological Human Vaccines Administered Orally Product Overview
      • 10.11.3 Tiantan Biological Human Vaccines Administered Orally Product Market Performance
      • 10.11.4 Tiantan Biological Business Overview
      • 10.11.5 Tiantan Biological Recent Developments
    • 10.12 EuBiologics
      • 10.12.1 EuBiologics Basic Information
      • 10.12.2 EuBiologics Human Vaccines Administered Orally Product Overview
      • 10.12.3 EuBiologics Human Vaccines Administered Orally Product Market Performance
      • 10.12.4 EuBiologics Business Overview
      • 10.12.5 EuBiologics Recent Developments
    • 10.13 Panacea Biotec Ltd
      • 10.13.1 Panacea Biotec Ltd Basic Information
      • 10.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Product Overview
      • 10.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Product Market Performance
      • 10.13.4 Panacea Biotec Ltd Business Overview
      • 10.13.5 Panacea Biotec Ltd Recent Developments
    • 10.14 Bio-Med
      • 10.14.1 Bio-Med Basic Information
      • 10.14.2 Bio-Med Human Vaccines Administered Orally Product Overview
      • 10.14.3 Bio-Med Human Vaccines Administered Orally Product Market Performance
      • 10.14.4 Bio-Med Business Overview
      • 10.14.5 Bio-Med Recent Developments
    • 10.15 Halfkin Bio-Pharmaceuticals
      • 10.15.1 Halfkin Bio-Pharmaceuticals Basic Information
      • 10.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Overview
      • 10.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Market Performance
      • 10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
      • 10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
  • 11 Human Vaccines Administered Orally Market Forecast by Region
    • 11.1 Global Human Vaccines Administered Orally Market Size Forecast
    • 11.2 Global Human Vaccines Administered Orally Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Human Vaccines Administered Orally Market Size Forecast by Country
      • 11.2.3 Asia Pacific Human Vaccines Administered Orally Market Size Forecast by Region
      • 11.2.4 South America Human Vaccines Administered Orally Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Human Vaccines Administered Orally by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Human Vaccines Administered Orally Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Human Vaccines Administered Orally by Type (2026-2035)
      • 12.1.2 Global Human Vaccines Administered Orally Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Human Vaccines Administered Orally by Type (2026-2035)
    • 12.2 Global Human Vaccines Administered Orally Market Forecast by Application (2026-2035)
      • 12.2.1 Global Human Vaccines Administered Orally Sales (K MT) Forecast by Application
      • 12.2.2 Global Human Vaccines Administered Orally Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.